Prenetics appoints longevity expert Dr. Darshan Shah to board

Prenetics, a global health technology company, has appointed renowned longevity expert Dr. Darshan Shah to its board of directors in London on March 15, 2023, to enhance the company's strategic direction in the expanding field of genetic testing and personalized health solutions. The addition of Dr. Shah brings significant expertise in longevity science to Prenetics' leadership team. With over 15 years of experience in biomedical research and aging studies, Dr. Shah has published extensively on the genetic markers of longevity and innovative approaches to healthspan extension. His research has been instrumental in bridging the gap between scientific discovery and practical applications in preventive healthcare. Prenetics, known for its pioneering work in at-home genetic testing and health diagnostics, has been expanding its portfolio to include comprehensive health and longevity assessment services. The company, which gained prominence during the COVID-19 pandemic for its large-scale testing operations, is now positioning itself at the forefront of the personalized medicine revolution. Dr. Shah's appointment is expected to accelerate the company's development of advanced biomarkers and intervention strategies aimed at promoting healthy aging and extending human lifespan.